Sclerodermic Cardiomyopathy-A State-of-the-Art Review
- PMID: 35328222
- PMCID: PMC8947572
- DOI: 10.3390/diagnostics12030669
Sclerodermic Cardiomyopathy-A State-of-the-Art Review
Abstract
Systemic sclerosis (SSc) is a chronic autoimmune disorder with unknown triggering factors, and complex pathophysiologic links which lead to fibrosis of skin and internal organs, including the heart, lungs, and gut. However, more than 100 years after the first description of cardiac disease in SSc, sclerodermic cardiomyopathy (SScCmp) is an underrecognized, occult disease with important adverse long-term prognosis. Laboratory tests, electrocardiography (ECG) and cardiovascular multimodality imaging techniques (transthoracic 2D and 3D echocardiography, cardiac magnetic resonance (CMR), and novel imaging techniques, including myocardial deformation analysis) provide new insights into the cardiac abnormalities in patients with SSc. This state-of-the-art review aims to stratify all the cardiac investigations needed to diagnose and follow-up the SScCmp, and discusses the epidemiology, risk factors and pathophysiology of this important cause of morbidity of the SSc patient.
Keywords: cardiac magnetic resonance; cardiomyopathy; echocardiography; speckle-tracking; strain; systemic sclerosis.
Conflict of interest statement
The authors declare no conflict of interest.
Figures



Similar articles
-
Multimodality imaging evaluation of Chagas disease: an expert consensus of Brazilian Cardiovascular Imaging Department (DIC) and the European Association of Cardiovascular Imaging (EACVI).Eur Heart J Cardiovasc Imaging. 2018 Apr 1;19(4):459-460n. doi: 10.1093/ehjci/jex154. Eur Heart J Cardiovasc Imaging. 2018. PMID: 29029074
-
Cardiovascular Imaging for Systemic Sclerosis Monitoring and Management.Front Cardiovasc Med. 2022 Mar 31;9:846213. doi: 10.3389/fcvm.2022.846213. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 35433887 Free PMC article. Review.
-
CMR feature tracking in cardiac asymptomatic systemic sclerosis: Clinical implications.PLoS One. 2019 Aug 21;14(8):e0221021. doi: 10.1371/journal.pone.0221021. eCollection 2019. PLoS One. 2019. PMID: 31433819 Free PMC article. Clinical Trial.
-
Subclinical progression of systemic sclerosis-related cardiomyopathy.Eur J Prev Cardiol. 2020 Nov;27(17):1876-1886. doi: 10.1177/2047487320916591. Epub 2020 Apr 19. Eur J Prev Cardiol. 2020. PMID: 32306757
-
Cardiovascular magnetic resonance in systemic sclerosis: "Pearls and pitfalls".Semin Arthritis Rheum. 2017 Aug;47(1):79-85. doi: 10.1016/j.semarthrit.2017.03.020. Epub 2017 Mar 31. Semin Arthritis Rheum. 2017. PMID: 28522072 Review.
Cited by
-
Non-Invasive Cardiac and Vascular Monitoring in Systemic Sclerosis: Impact of Therapy on Subclinical Dysfunction.Medicina (Kaunas). 2024 Dec 19;60(12):2080. doi: 10.3390/medicina60122080. Medicina (Kaunas). 2024. PMID: 39768959 Free PMC article.
-
Association between Left Atrial Function and Survival in Systemic Sclerosis.J Cardiovasc Dev Dis. 2024 Oct 7;11(10):310. doi: 10.3390/jcdd11100310. J Cardiovasc Dev Dis. 2024. PMID: 39452281 Free PMC article.
-
Cardiopulmonary Exercise Testing: Deciphering Cardiovascular Complications in Systemic Sclerosis.Rev Cardiovasc Med. 2025 Jan 21;26(1):25914. doi: 10.31083/RCM25914. eCollection 2025 Jan. Rev Cardiovasc Med. 2025. PMID: 39867169 Free PMC article. Review.
-
Cardiogenic shock in systemic sclerosis: a retrospective study of acute ventricular dysfunction.Rheumatol Int. 2025 Apr 26;45(5):125. doi: 10.1007/s00296-025-05874-8. Rheumatol Int. 2025. PMID: 40285931
-
Outcomes of myocarditis in systemic sclerosis: A 3-year follow-up.Rheumatol Immunol Res. 2024 Jul 15;5(2):117-125. doi: 10.1515/rir-2024-0015. eCollection 2024 Jun. Rheumatol Immunol Res. 2024. PMID: 39015842 Free PMC article.
References
Publication types
LinkOut - more resources
Full Text Sources